Lifeward Ltd. (LFWD) Latest Company News

Sep 1, 2026, 19:30 UTC
Lifeward announced the departure of its CFO, as part of the same management transition.
Source:
- wbjournal.com
Aug 31, 2026, 20:30 UTC
Mark Grant stepped down as President and Chief Executive Officer of Lifeward Ltd., effective August 31, 2026, and will transition to Senior Advisor on September 1, 2026. Josh Hexter was appointed Interim Chief Executive Officer and principal executive officer, with an annual base salary of $100,000.
Source:
- wbjournal.com
Aug 20, 2026, 00:00 UTC
Lifeward Ltd. appointed Yonason Greenwald and Haggai Zamir as Class III directors effective August 14, 2026, and appointed Avraham Gabay as Class III director and Chair of the Board effective August 20, 2026, while Nadav Kidron departed as director effective August 20, 2026.
Aug 14, 2026, 13:15 UTC
Lifeward Ltd. reported its financial results for the second quarter of 2026, with revenue increasing and operating performance improving as its capital-efficient distribution strategy gained momentum.
Source:
Aug 5, 2026, 12:00 UTC
Lifeward launched a pilot program with Ottobock Care to expand national access to its ReWalk Personal Exoskeleton in the United States.
Source:
- globenewswire.com
Jul 7, 2026, 20:15 UTC
Lifeward secured up to $11.2 million in strategic financing, with an initial $5.6 million drawn immediately and an additional $5.6 million available upon achieving milestones, to accelerate commercial expansion.
Source:
- globenewswire.com
Jul 7, 2026, 00:00 UTC
Lifeward Ltd. signed a securities purchase agreement to issue up to $11.16 million aggregate principal amount of senior secured convertible notes, with $5.58 million issued at closing on July 6, 2026, and the remainder subject to conditions.

LFWD

Lifeward announced the departure of its CFO, as part of the same management transition.

Lifeward Ltd. appointed Yonason Greenwald and Haggai Zamir as Class III directors effective August 14, 2026, and appointed Avraham Gabay as Class III director and Chair of the Board effective August 20, 2026, while Nadav Kidron departed as director effective August 20, 2026.

Lifeward Ltd. reported its financial results for the second quarter of 2026, with revenue increasing and operating performance improving as its capital-efficient distribution strategy gained momentum.

Lifeward launched a pilot program with Ottobock Care to expand national access to its ReWalk Personal Exoskeleton in the United States.

Lifeward secured up to $11.2 million in strategic financing, with an initial $5.6 million drawn immediately and an additional $5.6 million available upon achieving milestones, to accelerate commercial expansion.

Lifeward Ltd. signed a securities purchase agreement to issue up to $11.16 million aggregate principal amount of senior secured convertible notes, with $5.58 million issued at closing on July 6, 2026, and the remainder subject to conditions.